Local Clinical Trials for Prostate Cancer - Topix
Links shared publicly online about this topic.
- 196total visits
Local Clinical Trials for Prostate Cancer - Topix
View full resource at topix.com
Tags: Cancer, Prostate Cancer, Prostate, Clinical Trial, Men's Health
Most Recently Shared on June 24, 2011 at 2:23 am By:
Local Clinical Trials for Prostate Cancer: Prostate cancer has no or very minimal symptoms. That's why preventio... http://bit.ly/iVGpS0
AIM: Prostate cancer therapy trends moving in wrong direction
healthimaging.com — “Men with localized prostate cancer may not be receiving curative therapy (CTx) in accordance with potential clinical benefit, as patients with a low likelihood to benefit have received increasingly aggressive treatment in recent years while patients in groups that are likely to benefit from CTx have not seen comparable increases in treatment, according to a research letter published in the Feb. 27 issue of Archives of Internal Medicine.” View full resource at healthimaging.com
Most Recently Shared on February 27, 2012 at 11:33 pm By:
Health Imaging & IT Health Magazine
AIM: Prostate cancer therapy trends moving in wrong direction http://t.co/zPzduZYD
Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer
news-medical.net — “Tiltan Pharma Ltd. today announced that it has commenced a Phase 2 clinical trial of its anti-angiogenic product TL-118 for the treatment of pancreatic cancer.” View full resource at news-medical.net
Most Recently Shared on February 13, 2012 at 4:10 pm By:
Prostate Cancer: Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer: Tiltan Pharma Ltd. today ... http://t.co/91quBbZd
SMH.COM - Experimental Ovarian Cancer Vaccine Offers Hope for Local Cancer Patients
smh.com — “SMH.COM - Experimental Ovarian Cancer Vaccine Offers Hope for Local Cancer Patients” View full resource at smh.com
Most Recently Shared on February 2, 2012 at 5:53 pm By:
SMH first site in world approved to begin enrolling patients in international clinical trial. http://t.co/GXnkAXkT #cancer #sarasota
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival
medicalnewstoday.com — “A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular recept” View full resource at medicalnewstoday.com
Most Recently Shared on February 2, 2012 at 8:05 am By:
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival http://t.co/rocDqfAo #prostate
Researchers target multiple tumors in new cancer vaccine study - FierceVaccines
fiercevaccines.com — “Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or Read more...” View full resource at fiercevaccines.com
Most Recently Shared on January 26, 2012 at 2:06 pm By:
RT @FierceBiotech: Future threat to Provenge? New cancer vax study targets multiple tumors (prostate, lung, etc) http://t.co/oCAnW1wj
Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients
news-medical.net — “Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients.” View full resource at news-medical.net
Most Recently Shared on January 13, 2012 at 9:28 am By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients: Jefferson'... http://t.co/y7uUj2MD
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
medicalxpress.com — “Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually ...” View full resource at medicalxpress.com
Most Recently Shared on January 12, 2012 at 5:29 pm By:
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival http://t.co/vKvoOm9X
Arrowhead receives FDA IND approval for Adipotide obesity drug
news-medical.net — “Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.” View full resource at news-medical.net
Most Recently Shared on January 5, 2012 at 10:32 am By:
Obesity News: Arrowhead receives FDA IND approval for Adipotide obesity drug: Arrowhead Research Corporation, a ... http://t.co/WtTufwQY
Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer
news-medical.net — “Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.” View full resource at news-medical.net
Most Recently Shared on January 5, 2012 at 10:28 am By:
Meningitis News: Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer: Viamet Pharma... http://t.co/RLiZ4zPY
Soligenix reports results from orBec Phase 2 trial on acute GVHD
news-medical.net — “Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.” View full resource at news-medical.net
Most Recently Shared on December 12, 2011 at 3:10 pm By:
Prostate Cancer: Soligenix reports results from orBec Phase 2 trial on acute GVHD: Soligenix, Inc., a developmen... http://t.co/rU2LofNZ
NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on December 1, 2011 at 3:14 pm By:
NCI Cancer Bulletin Health News
Featured clinical trial: Novel combination chemotherapy for localized Ewing Sarcoma http://t.co/4ZHtRgz1
Researchers discover Achilles' heel in lethal form of prostate cancer
labspaces.net — “An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.” View full resource at labspaces.net
Most Recently Shared on November 17, 2011 at 8:45 pm By:
Researchers discover Achilles' heel in lethal form of prostate cancer - http://t.co/2khO1X7Y
Aurora kinase inhibitor may treat neuroendocrine prostate cancer
news-medical.net — “An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.” View full resource at news-medical.net
Most Recently Shared on November 17, 2011 at 9:49 am By:
Aurora kinase inhibitor may treat neuroendocrine prostate cancer: An international team of researchers led by cl... http://t.co/glKXgynH
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab
medicalnewstoday.com — “An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The stud” View full resource at medicalnewstoday.com
Most Recently Shared on November 16, 2011 at 10:06 am By:
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab http://t.co/1LkhIR3M #prostate
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial : The Lancet
lancet.com — “Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. By - Dr Padraig Warde MB, Malcolm Mason MB, Keyue Ding PhD, Peter Kirk...” View full resource at lancet.com
Most Recently Shared on November 3, 2011 at 5:01 pm By:
Advertisement
